Multidrug-resistant Escherichia coli bacteremia in cancer patients

American Journal of Infection Control

Volumn 37, Issue 9, 2009, Pages 741-745

  Vigil, Karen J ^a   Adachi, Javier A ^b   Aboufaycal, Halim ^a   Hachem, Ray Y ^b   Reitzel, Ruth A ^b   Jiang, Ying ^b   Tarrand, Jeffrey J ^b   Chemaly, Roy F ^b   Bodey, Gerald P ^b   Rolston, Kenneth V ^b   Raad, Isaam ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; CANCER PATIENT; CASE REPORT; CHEMOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE TRANSMISSION; ESCHERICHIA COLI; FEMALE; HOSPITAL ADMISSION; HUMAN; MALE; MULTIDRUG RESISTANCE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYMERASE CHAIN REACTION; RISK FACTOR;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; CROSS INFECTION; DNA FINGERPRINTING; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; NEOPLASMS; RISK FACTORS;

EID: 71249090838     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2009.02.002     Document Type: Article

References (31)

1. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., and Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39 (2004) 309-317
2. Reacher M.H., Shah A., Livermore D.M., Wale M.C., Graham C., Johnson A.P., et al. Bacteremia and antibiotic resistance of its pathogen reported in England and Wales between 1990 and 1998: trend analysis. BMJ 320 (2000) 213-216
3. Fluit A.C., Jones M.E., Schmitz F.J., Acar J., Gupta R., and Verhoef J. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clin Infect Dis 30 (2000) 454-460
4. Zinner S.H. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis 29 (1999) 490-494
5. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 to June 2001. Am J Infect Control 29 (2001) 404-421
6. Diekema D.J., Coffman S.L., Marshall S.A., Beach M.L., Rolston K.V., and Jones R.N. Comparison of activities of broad-spectrum β-lactam compounds against 1128 gram-positive cocci recently isolated in cancer treatment centers. Antimicrob Agents Chemother 43 (1999) 940-943
7. Fridkin S.K., Steward C.D., Edwards J., Pryor E.R., McGowan Jr. J.E., and Archibald L.K. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 29 (1999) 245-252
8. NNIS System. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32 (2004) 470-485
9. Neuhauser M.M., Weinstein R.A., Rydman R., Danziger L.H., Karam G., and Quinn J.P. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 289 (2003) 885-888
10. Lautenbach E., Strom B.L., Nachamkin I., Bilker W.B., Marr A.M., Larosa L.A., et al. Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms. Clin Infect Dis 38 (2004) 655-662
11. Cattaneo C., Quaresmini G., and Casari S. Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant E coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. J Antimicrob Chemother 61 (2008) 721-728
12. Peralta G., Sánchez M.B., Garrido J.C., De Benito I., Cano M.E., Martínez-Martínez L., et al. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with E coli bacteraemia. J Antimicrob Chemother 60 (2007) 855-863
13. Diekema D.J., Pfaller M.A., Jones R.N., Doern G.V., Winokur P.L., Gales A.C., et al. Survey of bloodstream infections due to gram-negative bacilli frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. Clin Infect Dis 29 (1999) 595-607
14. Fluit A.C., Jones M.E., Schmitz F.J., Acar J., Gupta R., and Verhoef J. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clin Infect Dis 30 (2000) 454-460
15. Sahm D.F., Thornsberry C., Mayfield D.C., Jones M.E., and Karlowsky J.A. Multidrug-resistant urinary tract isolates of E coli prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother 45 (2001) 1402-1406
16. Oteo J., Campos J., and Baquero F. Antibiotic resistance in 1962 invasive isolates of Escherichia coli in 27 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System. J Antimicrob Chemother 50 (2002) 945-952
17. Cullen M., Steven N., Billingham L., Gaunt C., Hastings M., Simmonds P., et al. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med 353 (2005) 988-998
18. Bucaneve G., Micozzi A., Menichetti F., Martino P., Dionisi M.S., Martinelli G., et al. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 353 (2005) 977-987
19. Gafter-Gvili A., Fraser A., Paul M., and Leibovici L. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med 142 (2005) 979-995
20. Cheong H.J., Yoo C.W., Sohn J.W., Kim W.J., Kim M.J., and Park S.C. Bacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea. Clin Infect Dis 33 (2001) 48-53
21. McDonald L.C., Chen F.J., Lo H.J., Yin H.C., Lu P.L., Huang C.H., et al. Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob Agents Chemother 45 (2001) 3084-3091
22. Richard P., Delangi M.H., Raffi F., Espaze E., and Richet H. Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant, gram-negative bacilli from gastrointestinal flora. Clin Infect Dis 32 (2001) 162-166
23. Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. CLSI document M100-S18. Enterobacteriaceae M7MIC (2008), Clinical and Laboratory Standards Institute, Wayne PA pp 98-101
24. Kern W.V., Klose K., Jellen-Ritter A.S., Oethinger M., Bohnert J., Kern P., et al. Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia. Eur J Clin Microbiol Infect Dis 24 (2005) 111-118
25. Baum H.V., Franz U., and Geiss H.K. Prevalence of ciprofloxacin-resistant Escherichia coli in hematologic-oncologic patients. Infection 28 (2000) 278-281
26. Gomez L., Garau J., Estrada C., Marquez M., Dalmau D., Xercavins M., et al. Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli. Cancer 97 (2003) 419-424
27. Lautenbach E., Fishman N.O., Bilker W.B., Castiglioni A., Metlay J.P., Edelstein P.H., et al. Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Arch Intern Med 162 (2002) 2469-2477
28. Tancrede C.H., and Andremont A.O. Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies. J Infect Dis 152 (1985) 99-103
29. Owens W.E., and Berg R.D. Bacterial translocation from the gastrointestinal tract of thymectomized mice. Curr Microbiol 7 (1982) 169-174
30. Steffn E.K., and Berg R.D. Relationship between cecal population levels of indigenous bacteria and translocation to the mesenteric lymph nodes. Infect Immun 39 (1983) 1252-1259
31. Bliklevens N.M. Implications of treatment-induced mucosal barrier injury. Curr Opin Oncol 17 (2005) 605-610